CIK 0001348362
- Non-accelerated filer
- Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 202000871
- Phone
- +1 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- 4 Open-market buy Chairman/CEO/President bought 3,000 shares at $0.37 ($1,095)
- 4 Open-market buy Chairman/CEO/President bought 11,000 shares at an average $0.35 ($3,845)
- 4 Open-market buy Chairman/CEO/President bought 15,500 shares at an average $0.30 ($4,720)
- 4 Open-market buy Chairman/CEO/President bought 4,000 shares at $0.34 ($1,360)
- 4 Open-market buy Chairman/CEO/President bought 4,500 shares at an average $0.32 ($1,440)
- 4 Open-market buy Chairman/CEO/President bought 8,500 shares at an average $0.33 ($2,767)
- 4 Open-market buy Chairman/CEO/President bought 5,000 shares at an average $0.34 ($1,688)
- 4 Open-market buy Chairman/CEO/President bought 20,088 shares at an average $0.31 ($6,176)
- 4 Open-market buy Chairman/CEO/President bought 110,000 shares at an average $0.21 ($23,000)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 21 · 420 filings